Prof Landray’s work seeks to further understand the determinants of common diseases through the design, conduct and analysis of large-scale clinical trials and prospective cohort studies. He leads international trials that have enrolled over 65,000 individuals, producing results that have changed regulatory drug approvals, influenced clinical guidelines and changed prescribing practice.
He is heavily involved in efforts to streamline clinical trials, working with regulatory agencies to facilitate efficient and cost-effective trials. He is a member of the Steering Committee of the FDA Clinical Trial Transformation Initiative, leading the Monitoring, Quality by Design and Mobile Clinical Trials projects. He serves as a member of the NHS Digital Research Advisory Group and leads the 21st Century Clinical Trials programme for Health Data Research UK.